What's in Croma-Pharma GmbH's pipeline?

Croma-Pharma GmbH has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Croma-Pharma GmbH's portfolio?

Top competitors by shared drug class: Allergan, Assistance Publique - Hôpitaux de Paris, EvergreenHealth, Helse Nord-Trøndelag HF, NICHD Pelvic Floor Disorders Network.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/croma-pharma-gmbh.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Croma-Pharma GmbH — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Croma-Pharma GmbH pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Botulinum toxin A "Botox Cosmetics"	Botulinum toxin A "Botox Cosmetics"	marketed	Neurotoxin; acetylcholine release inhibitor	SNARE complex (synaptosome-associated protein); acetylcholine release machinery	Dermatology; Aesthetics; Neurology
Botulinum Toxin A - Open Label	Botulinum Toxin A - Open Label	phase 3	Neurotoxin; Acetylcholine release inhibitor	SNAP-25 (synaptosome-associated protein of 25 kDa)	Neurology; Aesthetics; Pain Management

Therapeutic area mix

Dermatology; Aesthetics; Neurology · 1
Neurology; Aesthetics; Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
EvergreenHealth · 1 shared drug class
Helse Nord-Trøndelag HF · 1 shared drug class
NICHD Pelvic Floor Disorders Network · 1 shared drug class
NYU Langone Health · 1 shared drug class
The University of Texas Health Science Center, Houston · 1 shared drug class
Universidad Autonoma de Nuevo Leon · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Croma-Pharma GmbH:

Cite this brief

Drug Landscape (2026). Croma-Pharma GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/croma-pharma-gmbh. Accessed 2026-05-16.